The nuclear transcription factor NF-κB mediates interleukin-1β-induced expression of cyclooxygenase-2 in human myometrial cells

被引:160
作者
Belt, AR
Baldassare, JJ
Molnár, M
Romero, R
Hertelendy, F
机构
[1] St Louis Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63117 USA
[2] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63117 USA
[3] St Marys Hlth Ctr, St Louis, MO USA
[4] Semmelweis Univ Med, Inst Pathophysiol, H-1085 Budapest, Hungary
[5] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA
[6] NICHD, Perinatol Res Branch, Bethesda, MD USA
关键词
prostaglandins; cyclooxygenase; 2; expression; myometrium; immortalized myometrial cells; NF-kappa B activation; interleukin; 1;
D O I
10.1016/S0002-9378(99)70562-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Up-regulation of prostaglandin production by gestational tissues in the setting of intrauterine infection has been implicated as an important contributor to preterm labor and parturition. In this study we investigated the possible role of the nuclear transcription factor NF-kappa B in interleukin-1 signaling, leading to the expression of cyclooxygenase 2 and prostaglandin production in human myometrial cell cultures. STUDY DESIGN: Human myometrial smooth muscle cells from an immortalized line were used as a model system between passages 20 and 35. Growth-arrested cell cultures were stimulated with human recombinant interleukin 1, and the activation of NF-kappa B was assessed by the degradation of the inhibitory protein I kappa B alpha (Western analysis), as well as by nuclear binding of NF-kappa B by using an electrophoretic mobility shift assay. The abundance of cyclooxygenase-2 messenger ribonucleic acid and protein was measured by Northern and Western analyses, whereas prostaglandin (prostaglandin I-2 and prostaglandin E-2) production was determined by specific radioimmunoassays. RESULTS: Within 15 minutes of stimulation with interleukin 1, 90% of I kappa B-alpha was degraded. This was temporally associated with nuclear translocation and binding of NF-kappa B. Within 30 minutes, cyclooxygenase 2 messenger ribonucleic acid appeared, with steady-state levels increasing up to 4 hours. This was followed by an up to 80-fold increase in cyclooxygenase 2 protein and a corresponding time-dependent increase in prostaglandin production. When I kappa B-alpha degradation was blocked with calpain I inhibitor, NF-kappa B translocation, cyclooxygenase 2 messenger ribonucleic acid and protein expression, and prostaglandin synthesis were also inhibited. CONCLUSION: Stimulation of human myometrial cells with interleukin 1 leads to rapid activation of the transcription factor NF-kappa B, which is functionally linked to the expression of cyclooxygenase 2 messenger ribonucleic acid, protein, and prostaglandin synthesis.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 27 条
  • [1] STRUCTURE OF THE HUMAN CYCLO-OXYGENASE-2 GENE
    APPLEBY, SB
    RISTIMAKI, A
    NEILSON, K
    NARKO, K
    HLA, T
    [J]. BIOCHEMICAL JOURNAL, 1994, 302 : 723 - 727
  • [2] NF-kappa B: Ten years after
    Baeuerle, PA
    Baltimore, D
    [J]. CELL, 1996, 87 (01) : 13 - 20
  • [3] I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR
    BAEUERLE, PA
    BALTIMORE, D
    [J]. SCIENCE, 1988, 242 (4878) : 540 - 546
  • [4] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [5] REL-ASSOCIATED PP40 - AN INHIBITOR OF THE REL FAMILY OF TRANSCRIPTION FACTORS
    DAVIS, N
    GHOSH, S
    SIMMONS, DL
    TEMPST, P
    LIOU, H
    BALTIMORE, D
    BOSE, HR
    [J]. SCIENCE, 1991, 253 (5025) : 1268 - 1271
  • [6] REGULATION OF PROSTAGLANDIN ENDOPEROXIDE SYNTHASE (CYCLOOXYGENASE) ISOZYME EXPRESSION
    GOPPELTSTRUEBE, M
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 52 (04): : 213 - 222
  • [7] HENKEL T, 1993, NATURE, V365, P82
  • [8] CYTOKINE-INITIATED SIGNAL-TRANSDUCTION IN HUMAN MYOMETRIAL CELLS
    HERTELENDY, F
    ROMERO, R
    MOLNAR, M
    TODD, H
    BALDASSARE, JJ
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1993, 30 (2-3): : 49 - 57
  • [9] Karin M, 1998, CANCER J SCI AM, V4, pS92
  • [10] KERR LD, 1995, METHOD ENZYMOL, V254, P619